Cargando…
Extracellular vesicles in kidney disease
Extracellular vesicles are released by the majority of cell types and circulate in body fluids. They function as a long-distance cell-to-cell communication mechanism that modulates the gene expression profile and fate of target cells. Increasing evidence has established a central role of extracellul...
Autores principales: | , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9152665/ https://www.ncbi.nlm.nih.gov/pubmed/35641620 http://dx.doi.org/10.1038/s41581-022-00586-9 |
_version_ | 1784717696101777408 |
---|---|
author | Grange, Cristina Bussolati, Benedetta |
author_facet | Grange, Cristina Bussolati, Benedetta |
author_sort | Grange, Cristina |
collection | PubMed |
description | Extracellular vesicles are released by the majority of cell types and circulate in body fluids. They function as a long-distance cell-to-cell communication mechanism that modulates the gene expression profile and fate of target cells. Increasing evidence has established a central role of extracellular vesicles in kidney physiology and pathology. Urinary extracellular vesicles mediate crosstalk between glomerular and tubular cells and between different segments of the tubule, whereas circulating extracellular vesicles mediate organ crosstalk and are involved in the amplification of kidney damage and inflammation. The molecular profile of extracellular vesicles reflects the type and pathophysiological status of the originating cell so could potentially be exploited for diagnostic and prognostic purposes. In addition, robust preclinical data suggest that administration of exogenous extracellular vesicles could promote kidney regeneration and reduce inflammation and fibrosis in acute and chronic kidney diseases. Stem cells are thought to be the most promising source of extracellular vesicles with regenerative activity. Extracellular vesicles are also attractive candidates for drug delivery and various engineering strategies are being investigated to alter their cargo and increase their efficacy. However, rigorous standardization and scalable production strategies will be necessary to enable the clinical application of extracellular vesicles as potential therapeutics. |
format | Online Article Text |
id | pubmed-9152665 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | Nature Publishing Group UK |
record_format | MEDLINE/PubMed |
spelling | pubmed-91526652022-06-02 Extracellular vesicles in kidney disease Grange, Cristina Bussolati, Benedetta Nat Rev Nephrol Review Article Extracellular vesicles are released by the majority of cell types and circulate in body fluids. They function as a long-distance cell-to-cell communication mechanism that modulates the gene expression profile and fate of target cells. Increasing evidence has established a central role of extracellular vesicles in kidney physiology and pathology. Urinary extracellular vesicles mediate crosstalk between glomerular and tubular cells and between different segments of the tubule, whereas circulating extracellular vesicles mediate organ crosstalk and are involved in the amplification of kidney damage and inflammation. The molecular profile of extracellular vesicles reflects the type and pathophysiological status of the originating cell so could potentially be exploited for diagnostic and prognostic purposes. In addition, robust preclinical data suggest that administration of exogenous extracellular vesicles could promote kidney regeneration and reduce inflammation and fibrosis in acute and chronic kidney diseases. Stem cells are thought to be the most promising source of extracellular vesicles with regenerative activity. Extracellular vesicles are also attractive candidates for drug delivery and various engineering strategies are being investigated to alter their cargo and increase their efficacy. However, rigorous standardization and scalable production strategies will be necessary to enable the clinical application of extracellular vesicles as potential therapeutics. Nature Publishing Group UK 2022-05-31 2022 /pmc/articles/PMC9152665/ /pubmed/35641620 http://dx.doi.org/10.1038/s41581-022-00586-9 Text en © Springer Nature Limited 2022 This article is made available via the PMC Open Access Subset for unrestricted research re-use and secondary analysis in any form or by any means with acknowledgement of the original source. These permissions are granted for the duration of the World Health Organization (WHO) declaration of COVID-19 as a global pandemic. |
spellingShingle | Review Article Grange, Cristina Bussolati, Benedetta Extracellular vesicles in kidney disease |
title | Extracellular vesicles in kidney disease |
title_full | Extracellular vesicles in kidney disease |
title_fullStr | Extracellular vesicles in kidney disease |
title_full_unstemmed | Extracellular vesicles in kidney disease |
title_short | Extracellular vesicles in kidney disease |
title_sort | extracellular vesicles in kidney disease |
topic | Review Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9152665/ https://www.ncbi.nlm.nih.gov/pubmed/35641620 http://dx.doi.org/10.1038/s41581-022-00586-9 |
work_keys_str_mv | AT grangecristina extracellularvesiclesinkidneydisease AT bussolatibenedetta extracellularvesiclesinkidneydisease |